These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Viral safety of biological products and the concept of validation. Horaud F Dev Biol Stand; 1996; 88():19-24. PubMed ID: 9119135 [No Abstract] [Full Text] [Related]
14. [Leukocyte depletion of blood products: a requirement for improvement of quality and safety]. De Pauw BE; Van den Bos A Ned Tijdschr Geneeskd; 2000 Sep; 144(36):1754-6. PubMed ID: 10992905 [No Abstract] [Full Text] [Related]
15. Risk reduction in biotherapeutic products. Ill CR; Dehghani H Curr Opin Drug Discov Devel; 2009 Mar; 12(2):296-304. PubMed ID: 19333875 [TBL] [Abstract][Full Text] [Related]
16. Problems of contamination, exposure, and pollution in freeze-drying biological products. LaSalle B Dev Biol Stand; 1976 Oct; 36():201-5. PubMed ID: 1030420 [No Abstract] [Full Text] [Related]
18. [Problems in microbial safety of advanced therapy medicinal products. Squaring the circle]. Montag-Lessing T; Störmer M; Schurig U; Brachert J; Bubenzer M; Sicker U; Beshir R; Spreitzer I; Löschner B; Bache C; Becker B; Schneider CK Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jan; 53(1):45-51. PubMed ID: 20012926 [TBL] [Abstract][Full Text] [Related]
19. Licensing of protein products from the milk of transgenic animals. Validation for pathogen removal--a strategy. Wright G; Colman A; Cottom D; Williams M Dev Biol Stand; 1996; 88():269-76. PubMed ID: 9119150 [No Abstract] [Full Text] [Related]
20. Massively parallel sequencing: a new tool in virus discovery and vaccine safety. Onions D Bull Mem Acad R Med Belg; 2011; 166(10-12):404-6. PubMed ID: 23082505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]